A Study of MR001 Combined With Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) After First-line Therapy
PHASE1
This Phase Ib/IIa study is evaluating the safety, tolerability, pharmacokin...
A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors
PHASE1
Researchers are looking for a better way to treat people who have advanced ...
Status
Active Not Recruiting
Location
Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's
Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study
PHASE3
The primary objective of the study is to compare the complete response (CR)...
EDN Combined With TACE/HAIC and Second-Line Immune-Targeted Treatment Versus TACE/HAIC Alone in Locally Advanced HCC With Portal Vein Tumor Thrombosis After First-Line Therapy Failure: A Prospective, Multicenter, Randomized Controlled Trial
PHASE1
The goal of this clinical trial is to evaluate the efficacy and safety of c...
Status
Not Yet Recruiting
Location
Zhongda Hospital Affiliated to Southeast University, Department of Interventional and Vascular Surgery